• RESTRICT-seq Reveals KAT6A Dependency in SCC Resistance Mech

  2026-04-13

  The RESTRICT-seq study introduces a time-gated CRISPR screening approach to uncover epigenetic dependencies in squamous cell carcinoma (SCC) resistance. Notably, the research identifies KAT6A as a critical epigenetic vulnerability, refining our understanding of oncogene-induced senescence and informing future assay design.

• CK2 and ERK8 Inhibitor: Precision Control for Phase Separati

  2026-04-13

  Explore the scientific impact of 2-(4,5,6,7-tetrabromo-2-(dimethylamino)-1H-benzo[d]imidazol-1-yl)acetic acid, a potent small molecule inhibitor. Learn how this molecular tool advances phase separation research and kinase regulation beyond conventional approaches.

• GSK J4 HCl: JMJD3 Inhibitor Workflows for Epigenetic Researc

  2026-04-12

  GSK J4 HCl, a potent JMJD3 inhibitor from APExBIO, unlocks precise control of histone demethylation in inflammation and cancer models. This guide distills advanced workflows, troubleshooting tactics, and translational insights from benchmark studies, empowering researchers to maximize both experimental rigor and discovery impact.

• Indometacin Sodium: Protocols & Pitfalls in Anti-Inflammator

  2026-04-12

  Indometacin Sodium Trihydrate empowers inflammation, pain, and neuroregenerative research with validated protocols and high solubility. This guide delivers practical workflows, troubleshooting insights, and data-backed tips for maximizing reproducibility and translational relevance.

• Caspase-3 Fluorometric Assay Kit: Precision in Apoptosis Ana

  2026-04-11

  Unlock rapid, quantitative apoptosis research using the Caspase-3 Fluorometric Assay Kit. This guide translates advanced workflows and troubleshooting strategies into actionable steps, empowering scientists to reliably measure caspase activity and gain mechanistic insight into cell death pathways.

• Docetaxel in Cancer Chemotherapy Research: Applied Workflows

  2026-04-11

  Docetaxel (Taxotere) is a cornerstone in cancer chemotherapy research, offering unmatched control over cell cycle arrest and apoptosis in diverse tumor models. This guide delivers actionable protocols, troubleshooting tips, and workflow enhancements, integrating the latest findings on resistance mechanisms to ensure reproducible, high-impact results.

• Technical Use of Omecamtiv Mecarbil (CK-1827452) in Cardiac

  2026-04-10

  Omecamtiv Mecarbil (CK-1827452) is a selective cardiac myosin activator designed for research on systolic heart failure and cardiac contractility modulation. This compound is most appropriate in studies requiring controlled enhancement of cardiac muscle contraction via the myosin S1 domain, but is not suitable for non-cardiac myosin or cross-tissue applications. It should not be used when water-solubility or long-term solution stability are mandatory.

• Abiraterone Acetate: Advancing CYP17 Inhibition in Prosta...

  2026-04-10

  Leverage the unique potency and selectivity of abiraterone acetate, the 3β-acetate prodrug of abiraterone, to dissect androgen biosynthesis and resistance mechanisms in robust 2D and 3D prostate cancer models. This guide reveals streamlined protocols, troubleshooting strategies, and comparative insights for maximizing translational impact in castration-resistant prostate cancer research.

• Chlorpromazine HCl: Beyond Antipsychotic—A Frontier in Ho...

  2026-04-09

  Explore the multifaceted role of Chlorpromazine HCl as a dopamine receptor antagonist in neuropharmacology studies and host-directed antibacterial research. This article uniquely examines its emerging application in immune modulation and hypoxia brain protection, revealing new avenues for psychotic disorder and infection research.

• Caspase-3 Fluorometric Assay Kit: Advancing Precision in ...

  2026-04-08

  Explore how the Caspase-3 Fluorometric Assay Kit delivers unparalleled sensitivity for DEVD-dependent caspase activity detection, enabling groundbreaking advances in apoptosis and neurodegenerative disease research. Discover unique mechanistic insights and translational applications beyond conventional assay methods.

• Nilotinib (AMN-107): Precision BCR-ABL Inhibitor for Tran...

  2026-04-08

  Nilotinib (AMN-107) stands out as a highly selective tyrosine kinase inhibitor, empowering cancer researchers with precise modulation of BCR-ABL and KIT signaling in leukemia and solid tumor models. Its robust solubility, potent mutation-specific inhibition, and emerging immunomodulatory roles set new standards for experimental reproducibility and workflow efficiency.

• Erastin: Ferroptosis Inducer Advancing Cancer Biology Res...

  2026-04-07

  Erastin is a gold-standard ferroptosis inducer empowering cancer biology researchers to dissect iron-dependent, non-apoptotic cell death in RAS- and BRAF-mutant tumor models. Its unique mechanism—targeting system Xc⁻ and modulating VDAC—enables high specificity and reproducibility in oxidative stress assays and translational cancer research applications.

• Abiraterone Acetate: CYP17 Inhibitor for Prostate Cancer ...

  2026-04-07

  Abiraterone acetate, a potent 3β-acetate prodrug CYP17 inhibitor, is revolutionizing preclinical prostate cancer research by enabling precise androgen biosynthesis pathway interrogation in both 2D and advanced 3D spheroid models. This article offers actionable protocols, optimization strategies, and troubleshooting insights for leveraging Abiraterone acetate from APExBIO in castration-resistant prostate cancer workflows.

• Caspase-3 Fluorometric Assay Kit: Precision in DEVD-Depen...

  2026-04-06

  The Caspase-3 Fluorometric Assay Kit enables sensitive, quantitative DEVD-dependent caspase activity detection, a cornerstone for apoptosis assay workflows. Using a specific fluorogenic substrate, this APExBIO kit delivers rapid, reproducible results for caspase-3 activity measurement in cellular apoptosis and neurodegenerative research.

• Erastin: Ferroptosis Inducer Targeting RAS Mutant Tumor C...

  2026-04-06

  Erastin is a potent ferroptosis inducer that triggers iron-dependent, non-apoptotic cell death in tumor cells—especially those with oncogenic RAS or BRAF mutations. Its mechanism, validated in cancer biology research, disrupts redox homeostasis by inhibiting the cystine/glutamate antiporter system Xc⁻ and modulating the voltage-dependent anion channel. APExBIO's Erastin (B1524) is a benchmark tool for oxidative stress assays and ferroptosis pathway studies.

16098 records 1/1074 page Next 12345 下5页 Last page